Chemical inhibitors of MTCP-1 B1 include a variety of compounds that can impede the protein's function through interference with specific cellular signaling pathways. Phorbol 12-myristate 13-acetate (PMA) can activate protein kinase C (PKC), which in turn leads to phosphorylation and subsequent inhibition of MTCP-1 B1 activity. Staurosporine, a potent PKC inhibitor, can decrease phosphorylation of MTCP-1 B1, which is crucial for its activity, thereby inhibiting its function. Similarly, LY294002 and Wortmannin, as phosphoinositide 3-kinase (PI3K) inhibitors, can reduce the downstream signaling required for MTCP-1 B1 activation and thus inhibit the protein. The PI3K/Akt pathway plays a significant role in the regulation of MTCP-1 B1, and by disrupting this pathway, these inhibitors can suppress MTCP-1 B1 activity.
In parallel, Rapamycin, by inhibiting the mammalian target of rapamycin (mTOR), can have an impact on the signaling pathways that regulate protein synthesis and cell growth, which can lead to a decrease in MTCP-1 B1 activity. Triciribine, an Akt inhibitor, can also diminish the activation of downstream proteins that may include MTCP-1 B1. U0126 and PD98059, as inhibitors of MEK, can prevent the activation of ERK in the MAPK pathway, resulting in decreased activation of proteins regulated by this pathway, including MTCP-1 B1. Additionally, SP600125 and SB203580, which inhibit JNK and p38 MAPK, respectively, can lead to reduced activity of proteins involved in stress response pathways, such as MTCP-1 B1. PP2, an Src family kinase inhibitor, can decrease the phosphorylation and activity of MTCP-1 B1 by inhibiting kinases responsible for phosphorylation events. Lastly, Dasatinib, a broad-spectrum tyrosine kinase inhibitor, can also reduce the phosphorylation and activity of many proteins, including MTCP-1 B1, due to the protein's dependence on phosphorylation for its activity. These chemical inhibitors, by targeting specific kinases and pathways, can effectively inhibit the function of MTCP-1 B1.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is known to activate protein kinase C (PKC), which can lead to phosphorylation and subsequent inhibition of MTCP-1 B1 activity, as PKC-mediated phosphorylation can negatively regulate the activity of certain proteins. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent PKC inhibitor. By inhibiting PKC, it can decrease the phosphorylation of MTCP-1 B1, which is essential for its activity, resulting in functional inhibition of MTCP-1 B1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinase (PI3K) inhibitor, and by inhibiting PI3K, it can reduce the downstream signaling required for MTCP-1 B1 activation, leading to its functional inhibition. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that can obstruct the PI3K/Akt pathway, leading to decreased activity of MTCP-1 B1 due to the role of this pathway in MTCP-1 B1 regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mammalian target of rapamycin (mTOR), which is part of the signaling pathways that regulate protein synthesis and cell growth, potentially leading to decreased activity of MTCP-1 B1. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine is an Akt inhibitor, and by inhibiting Akt, it can suppress the activation of downstream proteins that may include MTCP-1 B1, leading to its functional inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which is upstream of ERK in the MAPK pathway; inhibition here can reduce ERK activity and thus decrease activation of proteins regulated by this pathway, including MTCP-1 B1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is another MEK inhibitor that prevents the activation of ERK, potentially leading to decreased activity of proteins regulated by this pathway, such as MTCP-1 B1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, part of the stress-activated MAPK pathway, and inhibition of JNK can lead to decreased activity of proteins regulated by stress response, including MTCP-1 B1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, and by inhibiting p38 MAPK, it can reduce the activity of proteins that are regulated by this stress-activated pathway, such as MTCP-1 B1. | ||||||